BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7654035)

  • 1. Oestrone sulphatase activity in normal and malignant breast tissues: relationship with tumour location.
    Chapman O; Purohit A; Wang DY; Ghilchik MW; Reed MJ
    Anticancer Res; 1995; 15(4):1467-71. PubMed ID: 7654035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control and expression of oestrone sulphatase activities in human breast cancer.
    Pasqualini JR; Chetrite G; Nestour EL
    J Endocrinol; 1996 Sep; 150 Suppl():S99-105. PubMed ID: 8943793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of aromatase and sulphatase in breast tumour cells.
    Purohit A; Wang DY; Ghilchik MW; Reed MJ
    J Endocrinol; 1996 Sep; 150 Suppl():S65-71. PubMed ID: 8943789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of tissue oestradiol levels in human breast cancer.
    Santen RJ
    Cancer Surv; 1986; 5(3):597-616. PubMed ID: 3555785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of oestrone sulphatase activity in the MDA-MB-231 breast cancer cell line by breast cyst fluid from Malaysian women.
    Elsadig RE; Reimann K; Yip CH; Lai LC
    Anticancer Res; 2001; 21(4A):2693-6. PubMed ID: 11724341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The origin of oestrone sulphate in normal and malignant breast tissues in postmenopausal women.
    Purohit A; Riaz AA; Ghilchik MW; Reed MJ
    Horm Metab Res; 1992 Nov; 24(11):532-6. PubMed ID: 1452119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of breast cyst fluid on oestrone sulphatase activity in MCF-7 breast cancer cells.
    Erbas H; Lennard TW; Lai LC
    Anticancer Res; 1996; 16(2):833-6. PubMed ID: 8687137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of oestrone sulphatase activity in breast cancer cell lines by growth factors.
    Purohit A; Chapman O; Duncan L; Reed MJ
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):563-6. PubMed ID: 1562528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of insulin-like growth factors I and II on oestrone sulphatase activity in human breast cancer cell lines.
    Hwa IA; Reimann K; Lim PK; Lai LC
    Int J Mol Med; 1999 Aug; 4(2):175-8. PubMed ID: 10402485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma.
    Evans TR; Rowlands MG; Law M; Coombes RC
    Br J Cancer; 1994 Mar; 69(3):555-61. PubMed ID: 8123487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of oestrone sulphatase activity by tibolone and its metabolites.
    Purohit A; Malini B; Hooymans C; Newman SP
    Horm Metab Res; 2002 Jan; 34(1):1-6. PubMed ID: 11832993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of retinoic acid and palm oil carotenoids on oestrone sulphatase and oestradiol-17beta hydroxysteroid dehydrogenase activities in MCF-7 and MDA-MB-231 breast cancer cell lines.
    Ng JH; Nesaretnam K; Reimann K; Lai LC
    Int J Cancer; 2000 Oct; 88(1):135-8. PubMed ID: 10962451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of subchronic administration of oestrone-3-O-sulphamate on oestrone sulphatase activity in liver, spleen and white blood cells of ovariectomized rats.
    Barth A; Römer W; Oettel M
    Arch Toxicol; 2000 Sep; 74(7):366-71. PubMed ID: 11043491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate.
    Purohit A; Williams GJ; Roberts CJ; Potter BV; Reed MJ
    Int J Cancer; 1995 Sep; 63(1):106-11. PubMed ID: 7558436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of oestrone sulphatase activity in white blood cells to monitor in vivo inhibition of steroid sulphatase activity by oestrone-3-O-sulphamate.
    Purohit A; Froome VA; Wang DY; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 1997 May; 62(1):45-51. PubMed ID: 9366497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4- and 6-(p-Sulphamoylphenyl)androstenediones: Studies of aromatase inhibitor-based oestrone sulphatase inhibition.
    Watari Y; Yamaguchi S; Takahashi M; Nagaoka M; Numazawa M
    Steroids; 2010 Dec; 75(12):891-6. PubMed ID: 20546769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of aromatase activity by cytokines, PGE2 and 2-methoxyoestrone-3-O-sulphamate in fibroblasts derived from normal and malignant breast tissues.
    Purohit A; Ghilchik MW; Leese MP; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):167-72. PubMed ID: 15862962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cytokines and sulphatase inhibitors in regulating oestrogen synthesis in breast tumours.
    Reed MJ; Purohit A; Duncan LJ; Singh A; Roberts CJ; Williams GJ; Potter BV
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):413-20. PubMed ID: 7626490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
    Miller WR; Stuart M; Sahmoud T; Dixon JM
    Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrone sulphatase activity in mammary tumours and the liver of N-nitrosomethylurea treated rats.
    Evans TR; Chander SK; Rowlands MG; Coombes RC
    Br J Cancer; 1992 Jan; 65(1):72-6. PubMed ID: 1733443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.